Drug raises stock price for Amgen

Amgen Inc.’s second-quarter earnings call Monday marked an upbeat note for the company, which raised its earnings and revenue guidance for the year. The company saw revenue increase 1 percent from a year ago, to $3.76 billion in the second quarter, and earnings per share decreased 3 percent, to 87 cents. Leaders were optimistic for the year after good stability in the first half. Amgen raised its guidance from a range of $14.2 billion to $14.6 billion up to a range of $14.6 billion to $14.9 billion. That would put the company closer to its revenue of $14.8 billion in 2007. For the full story visit www.venturacountystar.com/news/2008/jul/29/drug-raises-stock-price-for-amgen/